Blue Owl Capital Holdings’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Sell |
2,385,972
-50,000
| -2% | -$377K | 5.8% | 3 |
|
|
2025
Q1 | $18.4M | Buy |
2,435,972
+65,000
| +3% | +$492K | 5.95% | 3 |
|
|
2024
Q4 | $28.9M | Buy |
2,370,972
+360,000
| +18% | +$4.38M | 6.65% | 5 |
|
|
2024
Q3 | $33.7M | Sell |
2,010,972
-38,200
| -2% | -$639K | 6.49% | 5 |
|
|
2024
Q2 | $35.7M | Sell |
2,049,172
-875,670
| -30% | -$15.3M | 9.94% | 1 |
|
|
2024
Q1 | $49.8M | Sell |
2,924,842
-495,000
| -14% | -$8.43M | 9.96% | 2 |
|
|
2023
Q4 | $34.8M | Buy |
+3,419,842
| New | +$34.8M | 8.33% | 3 |
|